Testing AK0406 injection safety in healthy volunteers
Treatments studied
This study tests the safety and how the body processes a new drug called AK0406 in healthy adults. If you are generally healthy and match the age and weight requirements, you may be able to help researchers understand if the drug is safe before it is tested in people with a medical condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You are in good general health with no serious medical conditions.
- You have a body mass index (BMI) between 18 and 32.
- Men must weigh at least 110 pounds (50 kg) and women at least 99 pounds (45 kg).
- You agree to use effective birth control for 6 months after receiving the drug.
- You do not have any active infections like HIV, hepatitis B or C, or syphilis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new drug called AZD4916 in healthy people to see if it's safe and how the body processes it. It may help decide if the drug is safe enough for future studies.
This early-stage trial tests a new medicine called JMT206 in healthy people to see if it is safe and how the body handles it. Healthy volunteers, ages 18 to 60, are needed to help researchers learn about the drug's effects and how it moves through the body.
This trial tests a new medicine called AZD3974 in healthy people to see if it is safe and how the body handles it. It may help find the right dose for future studies.
This trial tests a new oral medication, ACI-19764, in healthy adults to see how safe it is and how the body processes it. It may help researchers understand how the drug affects the immune system, which could lead to future treatments for certain conditions.
This study tests a new injection called BPR-30221616 to see how safe it is and how people tolerate it. It is for healthy volunteers and will help find the right dose for future studies.
This is an early-stage safety test of a new investigational drug called HSK56630 in healthy volunteers with no major medical conditions. Researchers will monitor how your body tolerates the drug and what side effects might occur.
Hear when a new Healthy Participants trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.